Jamie P Dwyer Selected Research

ferric citrate

1/2017	Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis.
10/2015	Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.
9/2015	The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
9/2015	Ferric Citrate, an Iron-Based Phosphate Binder, Reduces Health Care Costs in Patients on Dialysis Based on Randomized Clinical Trial Data.
11/2014	Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data.
5/2013	Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
1/2013	Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jamie P Dwyer Research Topics

Disease

13	Chronic Kidney Failure (Chronic Renal Failure) 05/2022 - 06/2009
10	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2012
8	Chronic Renal Insufficiency 01/2022 - 01/2013
8	Albuminuria 01/2022 - 01/2012
7	Diabetic Nephropathies (Diabetic Nephropathy) 10/2020 - 01/2012
6	Hyperphosphatemia 01/2017 - 05/2013
5	Heart Failure 01/2022 - 11/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
5	Renal Insufficiency (Renal Failure) 10/2020 - 06/2009
4	Infections 01/2021 - 01/2016
4	Kidney Diseases (Kidney Disease) 10/2020 - 11/2014
3	Myocardial Infarction 01/2021 - 11/2014
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2021
2	Overweight 01/2019 - 11/2018
2	Weight Loss (Weight Reduction) 01/2019 - 11/2018
2	Hypertension (High Blood Pressure) 01/2017 - 03/2016
2	Anemia 09/2015 - 11/2014
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Diarrhea 01/2021
1	Disease Progression 10/2020
1	Body Weight (Weight, Body) 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Pyelonephritis 01/2019
1	Prediabetic State (Prediabetes) 11/2018
1	Hypercholesterolemia 01/2018
1	Bone Diseases (Bone Disease) 09/2015
1	Inflammation (Inflammations) 09/2015
1	Hypercalcemia (Milk Alkali Syndrome) 09/2015
1	Stroke (Strokes) 11/2014
1	Thrombosis (Thrombus) 01/2013
1	Proteinuria 02/2012
1	Diabetes Mellitus 01/2012
1	Glomerulonephritis 10/2011
1	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2011
1	Nephrogenic Fibrosing Dermopathy 06/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2009
1	Nephrogenic Diabetes Insipidus 03/2009

Drug/Important Bio-Agent (IBA)

7	Phosphates (Orthophosphate)IBA 05/2022 - 01/2013
7	CreatinineIBA 01/2021 - 02/2012
7	ferric citrateIBA 01/2017 - 01/2013
5	dapagliflozinIBA 01/2022 - 01/2019
5	IronIBA 01/2016 - 01/2013
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
4	AlbuminsIBA 01/2021 - 01/2012
4	Angiotensin IIIBA 10/2017 - 01/2012
4	Losartan (Cozaar)FDA LinkGeneric 10/2017 - 01/2012
4	Irbesartan FDA LinkGeneric 10/2017 - 01/2012
3	calcium acetate (Phoslo)FDA LinkGeneric 01/2017 - 09/2015
3	MineralsIBA 09/2015 - 01/2013
3	Insulin (Novolin)FDA Link 11/2014 - 01/2012
2	DiureticsIBA 01/2022 - 03/2016
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2014
2	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2020 - 01/2019
2	SodiumIBA 10/2020 - 01/2019
2	plazomicinIBA 01/2019 - 01/2019
2	lorcaserinIBA 01/2019 - 11/2018
2	5-HT2C Serotonin ReceptorIBA 01/2019 - 11/2018
2	Sevelamer (RenaGel)FDA Link 01/2017 - 09/2015
2	HematinicsIBA 10/2015 - 09/2015
2	Angiotensin Receptor AntagonistsIBA 02/2014 - 01/2012
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021
1	finerenoneIBA 10/2020
1	SymportersIBA 10/2020
1	AtrasentanIBA 10/2020
1	Meropenem (Merrem)FDA LinkGeneric 01/2019
1	VS 215IBA 11/2018
1	LipidsIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	alirocumabIBA 01/2018
1	Transferrin (beta 2 Transferrin)IBA 03/2017
1	Ferritins (Ferritin)IBA 03/2017
1	ThiazidesIBA 03/2016
1	AluminumIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 09/2015
1	Hemoglobins (Hemoglobin)IBA 09/2015
1	Phosphorus (Red Phosphorus)IBA 02/2015
1	pyridoxamine dihydrochlorideIBA 01/2015
1	Biological ProductsIBA 11/2014
1	Biomarkers (Surrogate Marker)IBA 02/2014
1	Citric Acid (Citrate)FDA LinkGeneric 01/2013
1	Reagent StripsIBA 02/2012
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2011
1	AntibodiesIBA 10/2011
1	gadodiamide (Omniscan)FDA Link 06/2009
1	Didanosine (Videx)FDA LinkGeneric 03/2009

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2012
3	Renal Dialysis (Hemodialysis) 05/2013 - 01/2013
1	Surgical Amputation (Amputations) 01/2021
1	Kidney Transplantation 01/2019
1	Heart-Assist Devices 02/2015
1	Transplantation 02/2015
1	Heart Transplantation (Grafting, Heart) 09/2014
1	Peritoneal Dialysis 01/2013
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2012
1	Catheters 06/2009